| | | | | |
AMPH Amphastar Pharmaceuticals, Inc. | $20,1800 | -2,56 % | $960,34M | $400,20K | |
REPL Replimune Group, Inc. | $11,0600 | -1,25 % | $960,31M | $4,32M | |
| $56,1900 | -1,21 % | $957,77M | $160,70K | |
AIO Virtus Artificial Intelligence & Technology Opportunities Fund | $28,0000 | +0,79 % | $957,06M | $55,48K | |
AVTX Avalo Therapeutics, Inc. Common Stock | $18,4800 | -4,20 % | $956,69M | $2,39M | |
HSLV Highlander Silver Corp. | $4,6600 | -2,31 % | $956,09M | $298,76K | |
| $54,8800 | +1,26 % | $955,17M | $89,46K | |
SANA Sana Biotechnology, Inc. Common Stock | $3,4800 | +0,87 % | $951,75M | $2,34M | |
ABX Abacus Global Management, Inc. | $10,7100 | -0,37 % | $950,59M | $744,52K | |
ANRO Alto Neuroscience Inc. | $26,3900 | -5,99 % | $948,94M | $424,10K | |
GDRX GoodRx Holdings, Inc. Class A Common Stock | $2,8700 | +0,70 % | $948,29M | $978,52K | |
RHLD Resolute Holdings Management, Inc. | $144,53 | +4,08 % | $948,28M | $253,08K | |
BTZ BlackRock Credit Allocation Income Trust | $10,2200 | -0,29 % | $948,17M | $332,52K | |
DBVT DBV Technologies S.A. | $16,3900 | +2,44 % | $947,57M | $240,92K | |
PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares | $13,6250 | +1,68 % | $947,08M | $6,97K | |
